Canada aims to make safety labeling changes to generic drugs timely with new pilot
This article was originally published in SRA
Executive Summary
Health Canada has launched a new pilot program to ensure generic drug makers are kept abreast of safety-related labeling changes to product monographs of reference branded drugs1,2. Providing generic companies with this information, it hopes, will help facilitate timely corresponding updates to generic product monographs.